Contract research organizations are companies that conduct research studies for the pharmaceutical, biotechnology, and medical device industries. They also provide scientific expertise to companies that need these services. Contract Research Organization List lists a wide variety of CROs, including large and small companies.
What Is a Contract Research Organization?
A Contract Research Organization (CRO) provides research services on a contract basis to the biotechnology, pharmaceutical, and medical device industries. These organizations are able to provide a wide range of research services at competitive prices, which makes them an ideal partner for a variety of industries. While there are many advantages to using a CRO, one of the main drawbacks is that they require substantial upfront investment, which may not be feasible for small companies.
In the early days of the computer age, CROs perform tasks like toxicology evaluations and clinical trials. As technology advance, their role expanded to encompass more complex tasks, including testing to evaluate the efficacy and safety of drugs and devices. They also conduct tests to determine bio-compatibility of implants under normal physiology. Finally, they may use tissue engineering techniques to test new drugs or improve existing ones in target disease models.
Clinical trials are complex exercises, and a CRO can provide all the resources necessary for a successful trial. Moreover, they can manage the obligations under a TORO, which saves both time and money for the Sponsor. Additionally, since clinical trials are time sensitive, CROs have the infrastructure and expertise to get the job done as soon as they’re call upon.
Vial is a global CRO with expertise in clinical trials. Vial has grow to become one of the largest CROs in the world. It employs over 17,000 people and covers more than 90 countries. The company has several locations throughout Asia, the U.S., Europe, and the Middle East, making it an ideal choice for drug companies seeking global coverage.
Vial
Vial is an established contract research organization (CRO) that manages a network of clinical research sites throughout the U.S. Vial’s mission is to accelerate the development of new therapies. Its goal is to save more lives by leveraging its technological expertise and streamlined clinical trials. The organization’s remote-first strategy has allowed it to grow and expand its operations.
The company recently opened a new office in San Francisco. Its executives were responsible for designing and building the office, which is housed in a clubhouse-style space. Vial’s executive team researched different Internet service providers before signing a lease and chose Meter.
Vial claims to be a “next-generation CRO” that promises better quality and speed in trials. The company’s technology platform powers trials end-to-end, including a modern Electronic Source and powerful tooling for CRAs. The company operates across multiple therapeutic areas and has more than 750 clinical trials.
The company’s executive team is led by Betsey Zbyszynski, head of clinical operations. The other members of the executive team are Jason Shuris, head of sales, Janet DuBois, principal researcher at DermResearch in Austin, Justin Withers, head of dermatology, and Mamta Hunt, head of quality. This team has more than 100 years of combined clinical trial experience in dermatology. Zbyszynski previously served as the director of client services for Intercept Pharmaceuticals and Symbio Research. She was also the vice president of DermNet Operations at DermTech International.
Vial’s Advisory Board includes top researchers from multiple therapeutic areas and continues to recruit experts in new areas. Vial’s unique approach leverages the expertise of its scientific advisors and its vast site network to accelerate and improve clinical trials. For example, Vial’s ophthalmology CRO uses digital technology and a proven enrollment playbook to deliver a more efficient and accurate patient database.
KCR
KCR has recently added a new chief technology officer to its team. Doug Bain has more than 20 years of experience in clinical trial technology solutions. He has led the implementation of an electronic data collection and is the founder and former CEO of the first virtual trial cloud platform, Clinpal.
In his new role at KCR, Doug plans to implement the latest trial technologies to help the company better serve its clients. KCR has established itself as one of the leading boutique contract research organizations, offering cross-regional, cross-region clinical trial services.
KCR provides clinical development solutions to the biotechnology, pharmaceutical, and medical device industries. With offices throughout North America, Central, and Eastern Europe, and the UK KCR has more than 2,800 employees. It offers services in three key areas: regulatory affairs, clinical project management, and safety/pharmacovigilance. Kiecana also offers quality assurance and clinical monitoring services. In addition, the company’s capabilities extend beyond clinical trials to include regulatory affairs and central laboratory services.
KCR has long-standing presence in the Ukraine with an office in the heart of Kyiv. It has over 40 experienced specialists and a strong network of local contacts. This makes it well positioned to serve as a strategic CRO for Pharma companies. Additionally, it offers a Bridge Plus Program to help companies start studies in CEE or CIS countries. This program offers clients the ease of a global CRO while maintaining their local quality standards.
PRA Health Sciences is one of the largest contract research organizations. It was founded in 1976 as the Anti-Inflammatory Drug Study Group and was renamed PRA in 1982. Today, it employs more than 17,000 people and provides coverage to more than 90 countries. In 2021, it will be acquired by global CRO leader ICON.
Read also: 6 Healthy Ways to Boost Your Immune System
Labcorp
Labcorp is a contract research organization (CRO) that provides services to pharmaceutical and biotechnology companies. The company recently announced a number of partnerships that are intended to streamline the process of drug development.
In April, Labcorp expanded its LaunchPad initiative to include the Covance CRO, a partnership that is expected to create an estimated $150 million in net savings over the next three years. In a statement, Labcorp said the acquisition will allow it to partner with clients in the biotech and pharmaceutical sectors in the Boston area. It is expected to close the transaction this quarter.
Labcorp is a large contract research organization that provides services across the entire drug development process. It has facilities around the world and provides services in multiple therapeutic areas. Some of its services include preclinical and clinical studies and commercialization. It also provides services in the areas of immunological, nonclinical pathology, and developmental toxicology.
In January 2020
Labcorp adopted Thermo Fisher Scientific’s Ion torrent generous system and the Oncomine precision assay. This collaboration enables Labcorp to leverage its clinical and health data to provide support to customers in the biotechnology and pharmaceutical industries. These partnerships are expected to result in incremental bookings over the next several years.
Labcorp has a global laboratory network. Its labs include routine, esoteric, and central laboratories. As a result, its laboratories can support drug development programs and help pharmaceutical and biotechnology companies run clinical trials to phase IV. The laboratory division contributed about 64% of the company’s total revenue in FY21. Its clinical development business contributes the remaining 36% of Labcorp’s revenue. It will continue to pursue new markets and enhance shareholder value through its clinical research and development operations.
In addition to providing contract research services, LabCorp has acquired Chiltern, a contract research organization. The company works with drugmakers to find new targets for their drugs, and then conduct clinical trials on behalf of these companies. The company charges the drugmaker’s a fee for its services and the contract research organization recruits and pays patients for those studies.
PPD
PPD is one of the largest global CROs and employs over 26,000 researchers. Their mission is to optimize the value of developing and delivering life-changing therapies. They provide clinical research for biotech, pharmaceutical, and medical device companies. They also offer services to academia and government organizations.
PPD has expanded its offerings in recent years through acquisitions. In 2017, it acquired Patheon for $7 billion, and in 2018, it acquired Brammer Bio for $1.7 billion. The acquisition has helped PPD become an even larger force in the clinical research industry. In addition to increasing its services, PPD also increased its global footprint by acquiring Bioclinica.
PPD is a global contract research organization that offers services in the discovery, development, and post-approval studies. It has offices around the world and serves pharmaceutical and biotechnology companies. PPD is a subsidiary of Thermo Fisher Scientific, which is headquartered in Wilmington, North Carolina. The company has over 27,000 employees worldwide.
In the biotech industry, contract research organizations are increasingly crucial. As the bridge between discovery and launch, they help life science organizations turn discoveries into breakthrough therapies. They also handle project management, data research, tests, and trials. They add value and speed to the process, while ensuring that the cost of the research is kept at a reasonable level.
Worldwide Clinical Trials
If you’re looking for a contract research organization to handle your clinical trial, you’ve come to the right place. Worldwide Clinical Trials offers a variety of services across the pharmaceutical, biotech, and medical device industries. They specialize in data-driven drug development, which allows them to produce compelling submissions that meet regulatory requirements. As a customer-centric CRO, they strive to provide the best service possible while helping their clients improve the quality of their lives.
Clinical Trial and Consulting Services have over 60 offices across the globe and extensive experience in a range of therapeutic areas. Their expertise includes oncology, cardiovascular, metabolic, rare diseases, and central nervous system diseases. In addition, they offer services in the area of biostatistics and medical writing.
CROs can be either public or nonprofit. The main difference between a nonprofit and for-profit organization is the independence of the organization. Nonprofit CROs are govern by academic oversight and public contracts, which guarantee their independence from for-profit entities. They also work with academic experts and minimize the risk of individual conflicts of interest.
The IQVIA Corporation was find in 1982 and now serves the health information technology and clinical research industries. They are one of the largest clinical research organizations in the world and have expand to more than 100 countries. IQVIA offers clinical trials as well as the associate laboratory and analytical services. They also offer strategic consulting services.